These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8782195)

  • 21. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.
    Ke LD; Shi YX; Im SA; Chen X; Yung WK
    Clin Cancer Res; 2000 Jun; 6(6):2562-72. PubMed ID: 10873113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.
    Bostick RM; Fosdick L; Grandits GA; Lillemoe TJ; Wood JR; Grambsch P; Louis TA; Potter JD
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1011-9. PubMed ID: 9419396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis.
    de Jong JS; van Diest PJ; van der Valk P; Baak JP
    J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer.
    Sun A; Shanmugam I; Song J; Terranova PF; Thrasher JB; Li B
    Prostate; 2007 Jun; 67(9):976-88. PubMed ID: 17440966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Do cell proliferation disorders play a crucial role in carcinogenesis?].
    Anikin IV; Pliss GB; Limarenko AIu
    Vopr Onkol; 1998; 44(1):126-30. PubMed ID: 9578747
    [No Abstract]   [Full Text] [Related]  

  • 26. Alterations in both heparan sulfate proteoglycans and mitogenic activity of fibroblast growth factor-2 are triggered by inhibitors of proliferation in normal and breast cancer epithelial cells.
    Lambrecht V; Le Bourhis X; Toillon RA; Boilly B; Hondermarck H
    Exp Cell Res; 1998 Dec; 245(2):239-44. PubMed ID: 9851863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines.
    Lane D; Gray EA; Mathur RS; Mathur SP
    Am J Reprod Immunol; 2005 Mar; 53(3):153-8. PubMed ID: 15727570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW; Lau KW; Tam PC; Shiu SY
    Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer: determinants and progression.
    Marahatta SB; Sharma N; Koju R; Makaju RK; Petmitr P; Petmitr S
    Nepal Med Coll J; 2005 Jun; 7(1):65-71. PubMed ID: 16295727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlations of insulin resistance and neoplasms].
    Suba Z; Ujpál M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferation of DU145 prostate cancer cells is inhibited by suppressing insulin-like growth factor binding protein-2.
    Chatterjee S; Park ES; Soloff MS
    Int J Urol; 2004 Oct; 11(10):876-84. PubMed ID: 15479293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
    Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
    Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The somatic mutation theory of cancer: growing problems with the paradigm?
    Soto AM; Sonnenschein C
    Bioessays; 2004 Oct; 26(10):1097-107. PubMed ID: 15382143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Environmental exposure to electromagnetic fields and the risk of cancer].
    Sliwińska-Kowalska M
    Med Pr; 1999; 50(6):581-91. PubMed ID: 10746244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer: the role of extracellular disease.
    Schwartz L; Balosso J; Baillet F; Brun B; Amman JP; Sasco AJ
    Med Hypotheses; 2002 Apr; 58(4):340-6. PubMed ID: 12027530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice.
    Dunn SE; Kari FW; French J; Leininger JR; Travlos G; Wilson R; Barrett JC
    Cancer Res; 1997 Nov; 57(21):4667-72. PubMed ID: 9354418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk of cancer among patients with cutaneous basal cell carcinoma].
    Frisch M; Hjalgrim H; Olsen JH; Melbye M
    Ugeskr Laeger; 1998 May; 160(19):2882-7. PubMed ID: 9599567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A criticism of karyokinetology as the key to the cancer problem].
    ROLSHOVEN E
    Med Welt (Stuttg); 1951 Dec; 20(50):1567-70. PubMed ID: 14940650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.